Mammalian mesoderm induction early response (mier) gene family
CA 2229440 A1 · Owner: Paterno, Gary David · Inventors: Paterno, Gary David; Gillespie, Laura Lee
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a family of mammalian genes that are transcribed in the immediate early phase following exposure to Fibroblast Growth Factors (FGF) during mesoderm induction termed Mesoderm Induction Immediate Early Response (MER) genes. Defining features of the members of this family include that these genes are a) transcribed in response to fibroblast growth factors (FGF); b) are expressed within 40 minutes of FGF treatment; and c) do not require protein synthesis for transcription. There are at least eleven members within this family. The invention relates generally to compositions of and diagnostic methods relating to the MER gene family, cDNA, nucleotide fragments polypeptides …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 21, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 21, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 21, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.